社团名称：

女性健康Womxn

社团介绍：

为什么要创立womxn?
当我们开始更加深入地思考健康问题，接触到更多科学知识时，你是否你是否知道，看似客观公正的现代医疗体系存在一些问题。这些问题对女性产生了深远的影响。尽管这些问题看起来像是合理的实验设计，但实际上它们反映了性别偏见。

数据和调查反映了一个惊人的事实，在大量的药物临床试验中，只有大约37%的受试者是女性。大量临床试验以“保护女性”的名义将她们排除在外，忽视了性别因素对药物效果的影响。这意味着，很多我们服用的药物，其安全性和有效性的数据，主要基于男性身体的研究结果。他们认为，如果一件事在男性身上时有道理的，那么在女性身上也一定有道理。

它们的假设成立吗？为什么会这样？过去很长一段时间，一种看似“善意”的想法主导了研究规则：为了保护女性免受潜在实验风险的伤害，倾向于将她们直接排除在早期临床试验之外。理由是担心药物可能对胎儿有害，或者影响女性的生殖系统。然而，这种“保护”忽视了女性的身体特点。女性胃酸较低，药物吸收率可能更高；雌激素影响多种药物的代谢。此外，女性更容易出现心电图假阳性，却被误诊为“焦虑”。 这种以“保护”为名的排除，造成了巨大的健康知识鸿沟。

为了改变现状，我们成立了女性健康社团-Womxn。我们致力于记录和分享女性的医疗体验，女性生理和健康知识，开展科普活动，让更多人了解女性在医疗中的需求。真正的保护，不是排除，而是平等的了解和精准的关怀。Why was Womxn founded?

As we delve deeper into health issues and acquire more scientific knowledge, you might be surprised to learn that the seemingly objective and impartial modern medical system has some problems that have a profound impact on women. Although these issues may appear to be reasonable experimental designs, they actually reflect gender bias.

Data and surveys reveal a startling fact: in a large number of drug clinical trials, only about 37% of the subjects are women. A significant number of clinical trials exclude women under the guise of “protecting them,” ignoring the impact of gender factors on drug efficacy. This means that the safety and effectiveness data of many drugs we take are primarily based on research conducted on male bodies. They assume that if something makes sense in men, it must also make sense in women.

Is this assumption valid? Why does it exist? For a long time in the past, a seemingly “well-intentioned” idea dominated research protocols: to protect women from potential experimental risks, they were often excluded from early clinical trials. The rationale was the concern that drugs might be harmful to fetuses or affect women’s reproductive systems. However, this “protection” overlooked the unique characteristics of women’s bodies. Women have lower stomach acid levels, which may lead to higher drug absorption rates; estrogen affects the metabolism of many drugs. Moreover, women are more likely to experience false positives in ECGs, which are often misdiagnosed as “anxiety.”

This exclusion in the name of “protection” has created a significant gap in health knowledge. To change this situation, we founded the Women’s Health Society—Womxn. We are committed to documenting and sharing women’s medical experiences, women’s physiology, and health knowledge, and conducting科普 activities to let more people understand the needs of women in healthcare. True protection is not exclusion, but equal understanding and precise care.

社团活动计划：

本学期将主要揭示当前医疗体系中存在的性别偏见问题。1.我们将分析为何在药物临床试验中女性参与者比例偏低，以及这种现象如何导致女性在用药安全性和有效性方面面临独特风险。2.我们会以生物专业知识的角度分析女性和男性在生理机能上的差异，讨论各健康领域中女性激素与生化特征的作用。本学期主要以这两个内容为主导展开，让同学们理解当今医疗体系是如何在整体以及特定的情况下影响女性健康。

This semester will primarily reveal the gender bias issues existing in the current medical system. 1. We will analyze why there is a low proportion of female participants in drug clinical trials and how this phenomenon leads to unique risks for women in terms of drug safety and efficacy. 2. We will analyze the differences in physiological functions between females and males from the perspective of biological expertise and discuss the role of female hormones and biochemical characteristics in various health fields. These two topics will be the main focus of this semester to help students understand how the current medical system affects women's health both generally and specifically.

2025-2026学年社长副社长：郑佳欣，何睿妍

2025-2026学年活动总结：